Myelofibrosis is a rare, chronic blood cancer in which scar tissue builds up in the bone marrow, crowding out normal blood cell production. It often develops gradually, sometimes as a progression from an earlier diagnosis of polycythemia vera or essential thrombocythemia. Living with myelofibrosis means coping with unpredictable fatigue, pain, and an uncertain long-term course, all of which can take a quiet but significant toll on emotional wellbeing.
A striking gap between what patients report and what doctors see
A multicenter survey of myelofibrosis patients and their physicians across India, published in BMC Cancer, surveyed 154 patients and 50 treating physicians in parallel about symptom burden and quality of life. Nearly all patients, 98%, reported that myelofibrosis had reduced their quality of life or work productivity, and 76% said the disease hindered their daily activities. But the most striking finding came from comparing what patients reported directly against what their physicians believed patients were experiencing. Physicians estimated that 63% of their patients were dealing with depression; patients themselves reported it at just 4%. Similar gaps appeared for sleep difficulties (8% of patients versus 70% physician estimate) and general inactivity (4% versus 66%). This is not evidence that physicians are wrong, or that patients are fine. It more likely reflects underreporting, stigma, or a simple absence of the right conversation. People living with myelofibrosis may not name what they are feeling as depression, may minimize it out of stoicism or fear of being seen as a burden, or may simply never have been asked directly.
Practical ways to cope
- Name what you're feeling, even tentatively You don't need a clinical label to describe what's happening. If a doctor's checklist-style question doesn't capture your experience, try describing it in your own words: low energy that isn't just physical tiredness, a sense of dread before appointments, irritability that feels out of character. Specific, personal language often opens a more useful conversation than a yes-or-no answer.
- Expect fatigue to have both physical and emotional layers Myelofibrosis fatigue is not ordinary tiredness, and it's easy to assume it's purely physical. But persistent fatigue is also strongly linked to low mood and anxiety. Treating both the physical symptom and its emotional weight, rather than assuming one will resolve once the other improves, tends to work better than treating either in isolation.
- Build a routine around uncertainty, not around good days Fluctuating symptoms can make planning feel pointless. Instead of waiting for a good day to resume meaningful activity, try building small, flexible anchors into most days: a short walk, a call with a friend, a few minutes outside. Routines that don't depend on feeling well are more sustainable than ones that do.
- Bring a written symptom and mood log to appointments Given how wide the gap can be between what patients report and what physicians perceive, a brief written log covering mood, sleep, and energy over the prior weeks can help bridge that gap more reliably than recall in the moment. It also signals to your care team that these symptoms matter to you and are worth tracking.
- Connect with others managing a myeloproliferative neoplasm Myelofibrosis is rare enough that many patients have never met another person with the same diagnosis. Online and in-person support communities for myeloproliferative neoplasms can reduce the isolation of managing an uncommon illness and offer practical, lived-experience advice that a clinical setting may not provide.
Symptom relief and quality of life are connected, not separate goals
The phase 3 MOMENTUM trial, published in HemaSphere, studied symptomatic and anemic myelofibrosis patients treated with momelotinib versus danazol, tracking outcomes with the Myelofibrosis Symptom Assessment Form alongside broader quality-of-life and patient-reported-outcome measures. Patients receiving momelotinib showed meaningfully greater and faster improvement across nearly every symptom domain, including fatigue and physical functioning, with benefits appearing within the first month of treatment and continuing to build over time. The significance for mental health is less about any single medication and more about what the trial demonstrates: symptom burden in myelofibrosis is not fixed. When physical symptoms like fatigue, pain, and reduced functioning are actively treated and tracked, patients' broader sense of wellbeing improves alongside them. Quality of life in myelofibrosis should not be treated as a secondary concern to be addressed only after the disease itself is under control; the two move together.
Talking with your care team about the parts that are hard to name
Because physicians in the India survey so dramatically overestimated certain symptoms their patients weren't reporting, it's worth considering that the usual dynamic, patients needing to advocate to be believed, may sometimes run the other way in myelofibrosis: physicians may already suspect more distress than you are describing, and may simply be waiting for an opening to ask. If a doctor asks how you're coping emotionally, it is rarely a routine or throwaway question. Taking it seriously, and answering honestly even when the honest answer is complicated or hard to summarize, can shift the kind of support you're offered, from purely physical management toward something that also addresses what's happening underneath it.
Living well alongside a chronic, evolving illness
- Separate the disease's uncertainty from your day-to-day choices You can't control how myelofibrosis will progress, but you can control how you spend the parts of a day when you do feel capable. Focusing energy on what's within reach today, rather than on long-range unknowns, tends to protect mood better than trying to resolve uncertainty that genuinely can't be resolved yet.
- Ask directly about psychological support, don't wait to be offered it Mental health support is not automatically built into most myelofibrosis treatment plans. If it would help to speak with a counselor, psychologist, or social worker familiar with chronic or hematologic illness, ask your care team for a referral directly rather than waiting for it to come up.
- Watch for withdrawal, not just sadness Depression in chronic illness doesn't always look like visible sadness. It can look like quietly withdrawing from people, letting go of hobbies, or losing interest in things that used to matter, while still functioning day to day. These quieter signs are easy for both patients and physicians to miss or dismiss as simple tiredness.
- Loop in the people close to you, deliberately Family and close friends often want to help but don't know how, especially with an illness most people have never heard of. A short, honest explanation of what myelofibrosis is and what kind of support actually helps, whether that's practical help, company, or simply not being asked how you're doing every single day, can make their support more useful and less draining for you.
- Revisit your emotional baseline periodically, not just at diagnosis Myelofibrosis can progress slowly over years, and emotional adjustment isn't a single event you complete once. Checking in with yourself every so often, the same way you'd track a physical symptom, can catch a gradual decline in mood before it becomes harder to address.